Finance

Beta
Lists
PHCUF:OTCMKTS
Photocure ASA
$6.22
-15.83%
(-1.17) 1D
Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHCUF...
Open
$6.22
High
$6.22
Low
$6.22
Avg. vol.
4.00
Volume
130.00
52-wk high
$7.39
52-wk low
$4.95
Beta
-0.02
Shares outstanding
27.12M
No. of employees
100
Open
$6.22
High
$6.22
Low
$6.22
Avg. vol.
4.00
Volume
130.00
52-wk high
$7.39
52-wk low
$4.95
Beta
-0.02
Shares outstanding
27.12M
No. of employees
100
News stories
From sources across the web
Profile
Photocure ASA is a Norwegian specialty pharma company that develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technology. Photocure's strategy in cancer is to continue the commercialization of Hexvix for bladder cancer diagnostics, and continue the development of the cancer portfolio and out-license prior to phase III studies. This strategy is based on a strong platform of intellectual property in photodynamic therapy. Wikipedia
About Photocure ASA
CEO-
Employees100
Founded1993
Headquarters-
SectorPharmaceutical industry
Websitephotocure.com
Previous reportsAll values in NOK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in NOK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
135.62M
134.96M
136.67M
264.61M
Cost of goods sold
10.04M
11.89M
10.93M
10.35M
Cost of revenue
10.04M
11.89M
10.93M
10.35M
Research and development expenses
506.00K
-862.00K
-415.00K
529.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
89.01M
93.60M
103.93M
99.59M
Operating expense
118.12M
120.69M
131.25M
133.58M
Total operating expenses
128.16M
132.57M
142.18M
143.93M
Operating income
7.46M
2.39M
-5.51M
120.68M
Other non operating income
-
-
-338.00K
1.00K
EBT including unusual items
2.51M
-398.00K
-9.42M
109.42M
EBT excluding unusual items
2.51M
-398.00K
-9.42M
109.42M
Income tax expense
-2.35M
-4.38M
-1.47M
26.00M
Effective tax rate
-93.55%
1,100.75%
15.57%
23.76%
Other operating expenses
28.60M
27.95M
27.74M
33.46M
Net income
4.86M
3.98M
-7.95M
83.42M
Net profit margin
3.59%
2.95%
-5.82%
31.53%
Earnings per share
-
0.15
-0.30
-
Interest and investment income
4.97M
4.22M
1.76M
9.41M
Interest expense
-9.91M
-7.50M
-2.15M
-20.67M
Net interest expenses
-4.94M
-3.28M
-397.00K
-11.26M
Depreciation and amortization charges
-
-
-
-
EBITDA
14.76M
9.72M
644.00K
126.55M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer